| Description |
1 online resource (174 p.) |
| Contents |
Cover -- Half Title -- Title -- Copyright -- Contents -- Authors -- Chapter 1 Introduction -- 1.1 What Is Nano? -- 1.2 The Structure -- 1.3 The Place of Novelty in Innovation -- 1.4 The Definition of Nanomedicine -- 1.5 Can the Definition of the Nano (Nanosciences and Nanotechnology) Be Limited to Size? -- 1.6 To Go Further -- 1.7 References -- Chapter 2 Nanopharmacy: What Is New With the Nano? -- 2.1 The Nanomedical Strategy -- 2.2 Isn't Everything Nano? -- 2.3 Titanium and Other Nano-metals -- 2.4 Nanopharmaceuticals by Design |
|
2.5 The Bottom-up Paradigm of Molecular Design Applied to Drugs -- 2.6 From Empirical Plant-Based Recipes to Industrial Products: Ushering in a New Era of Chemotherapy? -- 2.7 Paul Ehrlich, Magic Bullets, Receptors, and the Lock and Key Analogy -- 2.8 Nanopharmacy as Drug Design -- 2.9 Vectors and Encapsulation -- 2.10 Basic Nanomaterials: Chylomicrons, Micelles and Liposomes -- 2.11 Man-Made Micelles and Liposomes -- 2.12 The First Generation-Liposomal Vectors -- 2.13 The Second Generation-PEGylation -- 2.14 The Third Generation-Nanomaterials With Specifically Modified Surfaces |
|
2.14.1 Multi-functional Vectors -- 2.14.2 Albumin as the New Nanoparticle Standard -- 2.15 Is Nanopharmacy a Medical Revolution? -- 2.16 Pharmacy Is Not Always What It Seems -- 2.17 To Go Further -- 2.18 References -- Chapter 3 Theranostics: Toward a New Integrative Horizon -- 3.1 Theranostics-A Broad Definition -- 3.2 Breast Cancer: Appropriate Treatments for Different Tumors -- 3.3 Radioligand Therapy-The Dual Functionality of Radioactivity -- 3.4 Remote Guidance and Imaging-The Theranostic Potential of Magnetic Nanoparticles -- 3.5 The Prostate-Specific Antigen (PSA) and Prostate Cancer |
|
3.6 Transferrin and Biological Barriers. Another Form of Theranostics? -- 3.7 Visualizing Folate Receptors During Surgery -- 3.8 Diagnosis and Treatment: The Dawning of a New Era? -- 3.9 Theranostics and Precision Medicine: Refining and Individualizing Treatment -- 3.10 Genetics and Cancer -- 3.11 To Go Further -- 3.12 References -- Chapter 4 Health Under Surveillance -- 4.1 In Vivo, In Vitro, In Silico: The Inversion of Scales in Genetic Analysis -- 4.1.1 Probes-A Future Outside the Array? -- 4.1.2 NBIC Convergence and Nanoelectronics -- 4.2 To Go Further -- 4.3 References |
|
Chapter 5 Genetic Nanomedicine -- 5.1 Using Nanoparticles to Integrate Elements of Nucleic Acids Into Cells -- 5.2 The Use of NPs for Vaccination Against Infectious Diseases -- 5.2.1 How Vaccines Fit Into Nanomedicine -- 5.3 References -- Chapter 6 Toxicology of Nanomaterials: A New Toxicology? -- 6.1 New Methods, New Possibilities, New Investigations -- 6.2 Entry Into the Body: The Three Principal Routes -- 6.2.1 The Skin -- 6.2.2 The Lungs -- 6.2.3 The Intestines -- 6.3 The Blood-Brain Barrier: An Inner Frontier -- 6.4 The Distribution of Nanoparticles in the Body |
| Summary |
The book is an introduction to nanomedicine informed by a philosophical reflection about the domain and recent developments. It is an overview of the field, sketching out the main areas of current investment and research |
| Notes |
Description based upon print version of record |
|
6.4.1 The Metabolism of Nanoparticles |
| Form |
Electronic book
|
| Author |
Rihn, Bertrand H
|
| ISBN |
9781000841909 |
|
1000841901 |
|
